TARS
Tarsus Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arsusrx.com
- Employees(FY) 87
- ISIN US87650L1035
Performance
+12.34%
1W
+9.57%
1M
+24.56%
3M
+115.68%
6M
+88.84%
YTD
+140.05%
1Y
Profile
Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Investment Analysis Report: TARS
Overview
In this investment analysis report, we will delve into the financial statements of TARS, a company in the Health Technology sector specializing in Pharmaceuticals. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's financial health, growth p...
Technical Analysis of TARS 2024-05-10
Overview:
In analyzing the technical indicators for TARS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-05-12 08:32
- 2024-05-10 07:20
- 2024-05-09 17:00
- 2024-05-09 12:48
- 2024-05-09 11:06
- 2024-05-09 05:00
- 2024-05-09 03:49
- 2024-05-09 00:48
- 2024-05-08 17:40
- 2024-05-08 16:05
- 2024-05-08 08:58
- 2024-05-08 05:40
- 2024-05-08 04:05
- 2024-05-06 09:55
- 2024-05-05 21:55
- 2024-05-01 17:00
- 2024-05-01 05:00
- 2024-04-23 08:30
- 2024-04-22 20:30
- 2024-04-19 07:35
- 2024-04-08 19:35
5 Best Biotech ETFs To Buy(Insidermonkey)
- 2024-04-08 09:55
- 2024-04-07 21:55
- 2024-04-04 11:33
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts(Insider Monkey)
- 2024-04-03 23:33
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts(Insidermonkey)
- 2024-04-01 12:00
- 2024-04-01 00:00
- 2024-03-06 09:55
- 2024-03-05 20:55
- 2024-03-05 16:30
Tarsus to Participate at Upcoming Investor Conferences(GlobeNewswire)
Page 1 of 6
previousnext